Table 3 Relationships of the presence of anti-Bmi-1 autoantibody with clinicopathologic variables.
From: Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
| Â | Â | Â | Anti-Bmi-1 | Â | |
|---|---|---|---|---|---|
Characteristics | Total (n = 159) | OD ± SD | Negative cases 61.0% | Positive cases 39.0% | P |
Stage | Â | Â | Â | Â | 0.040 |
   I | 6 | 0.1883 ± 0.0459 | 6(100) | 0(0.0) |  |
   II | 72 | 0.2274 ± 0.0795 | 46(63.9) | 26(36.1) |  |
   III | 69 | 0.2394 ± 0.0932 | 39(56.5) | 30(43.5) |  |
   IV | 12 | 0.2441 ± 0.0755 | 5(41.7) | 7(58.3) |  |
pT classification | Â | Â | Â | Â | 0.747 |
   T1 | 9 | 0.1983 ± 0.0552 | 8(88.9) | 1(11.1) |  |
   T2 | 40 | 0.2312 ± 0.0815 | 22(55.0) | 18(45.0) |  |
   T3 | 80 | 0.2389 ± 0.0857 | 49(61.2) | 31(38.8) |  |
   T4 | 30 | 0.2230 ± 0.0927 | 18(60.0) | 12(40.0) |  |
pN classification | Â | Â | Â | Â | <0.001 |
   YES | 75 | 0.2596 ± 0.0826 | 35(46.7) | 40(53.3) |  |
   NO | 84 | 0.2067 ± 0.0787 | 62(73.8) | 22(26.2) |  |
pMetastasis | Â | Â | Â | Â | 0.170 |
   YES | 12 | 0.2441 ± 0.0755 | 5(41.7) | 7(58.3) |  |
   NO | 147 | 0.2385 ± 0.0858 | 91(61.9) | 56(38.1) |  |